CC(=O)OC1(Sc2ccccc2)CC2[C@H]3COC(C)(C)O[C@H]3CC[C@@]2(C)CC1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?